Lv2
182 积分 2022-04-18 加入
High‐Performance Liquid Chromatography–Ultraviolet Assay for the Determination of Pirtobrutinib Levels in a Patient With Mantle Cell Lymphoma
1个月前
已完结
Free Analyte Qc Concept: A Novel Approach to Prove Correct Quantification of Free Therapeutic Protein Drug/Biomarker Concentrations
1个月前
已完结
Free Analyte Qc Concept: A Novel Approach to Prove Correct Quantification of Free Therapeutic Protein Drug/Biomarker Concentrations
1个月前
已关闭
Best Practices in mAb and Soluble Target Assay Selection for Quantitative Modelling and Qualitative Interpretation
3个月前
已完结
Interference in a Neutralizing Antibody Assay for Odronextamab, a CD20xCD3 Bispecific mAb, from Prior Rituximab Therapy and Possible Mitigation Strategy
5个月前
已完结
Assessment of Neutralizing Antibody Activity in Clinical Studies: Use of Surrogate Measurements Instead of Stand-alone Assays
9个月前
已完结
Whole Blood Or Plasma: What is the Ideal Matrix for pharmacokinetic-driven Drug Candidate selection?
11个月前
已完结
Regulated bioanalysis of antibody-drug conjugates using LC-MS
11个月前
已完结
Bioanalysis for PK for antibody drug conjugates using ligand binding assay–challenges and bioanalytical strategies
1年前
已完结
Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy
1年前
已完结
皖公网安备34019202002308
